ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,525,321, issued on Jan. 13, was assigned to INCEREBRO Co. LTD. (Seoul, South Korea) and KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG CAMPUS (Sejong-si, South Korea).
"Method and device for designing target-specific drug in which deep-learning algorithm is combined with water pharmacophore model" was invented by Eun Sung Cho (Seoul, South Korea), Minsup Kim (Seoul, South Korea), Kichul Park (Seoul, South Korea) and Wonsang Kim (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method and device for designing a target-specific drug in which a deep learning algorithm is combined with a water ...